OBJECTIVE To summarize and analyze the deficiencies of quality control found in the process of drug certification inspection in Liaoning province in recent years, so as to provide reference for supervision and industry. METHODS The quality control deficiencies of 197 times certified by Liaoning province from 2017 to 2019 were summarized, and the high-frequency deficiencies were summarized and analyzed. RESULTS AND CONCLUSION The system of permit-holders for the sale of pharmaceuticals(MAH) or the consignee should strengthen the training of personnel, measurement and verification, laboratory management, to control the risk in quality control.
WANG Xiao, GAO Yong-bao, WANG Lu, MA Hui, WEI Jing.
Quality Control Deficiencies Analysis of Drug GMP Inspection of 2017-2019 in Liaoning Province[J]. Chinese Pharmaceutical Journal, 2020, 55(23): 1932-1934 https://doi.org/10.11669/cpj.2020.23.005
[1] Committee for Terms in Management Science and Technology. Terms in Management Science and Technology(管理科学技术名词) [M]. Beijing:Science Press,2016:254. [2] LIANG Y, ZHOU W Y, SUN H Y. On the relationship between quality assurance, quality control and GMP [J]. Mod Manag Sci(现代管理科学), 2013,(10):103-105. [3] Ministry of Health, PRC. Decree No. 79 of the Ministry of health. Good manufacturing practice for drugs (Revised in 2010) [药品生产质量管理规范(2010年修订)][S]. 2011.